LT - 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-18-methyl- prostaglandin E1 for treating inflammatory bowel disease
EN - 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-18-methyl- prostaglandin E1 for treating inflammatory bowel disease
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/4152 |
|
European patent
| (11) |
Number of the document |
2384791 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
11170933.3 |
|
Date of filing the European patent application |
2006-03-22 |
| (97) |
Date of publication of the European application |
2011-11-09 |
| (45) |
Date of publication and mention of the grant of the patent |
2016-06-15
|
| (46) |
Date of publication of the claims translation |
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
663200 P |
2005-03-21
|
US |
|
679920 P |
2005-05-11
|
US |
|
721976 P |
2005-09-30
|
US |
Inventors
| (72) |
Ueno, Ryuji, US
Kuno, Sachiko, US
Blikslager, Anthony T., US
Moeser, Adam J., US
|
Grantee
| (73) |
Sucampo AG,
Baarerstrasse 22, 6300 Zug,
CH
NORTH CAROLINA STATE UNIVERSITY,
4700 Hillsborough Street, Raleigh, NC 27606,
US
|
Title
| (54) |
13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-18-methyl- prostaglandin E1 for treating inflammatory bowel disease |
| |
13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-18-methyl- prostaglandin E1 for treating inflammatory bowel disease |
